Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D

Med Hypotheses. 1986 Oct;21(2):193-200. doi: 10.1016/0306-9877(86)90010-1.


A group of young patients having multiple sclerosis was treated with dietary supplements containing calcium, magnesium and vitamin D for a period of one to two years. The experimental design employed self-pairing: the response of each patient was compared with his/her own case history as control. The number of exacerbations observed during the program was less than one half the number expected from case histories. No side effects were apparent. The dietary regimen may offer a new means of controlling the exacerbation rate in MS, at least for younger patients. The results tend to support a theory of MS which states that calcium and magnesium are important in the development, structure and stability of myelin.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Calcium, Dietary / administration & dosage*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Magnesium / administration & dosage*
  • Male
  • Multiple Sclerosis / drug therapy*
  • Myelin Sheath / drug effects
  • Recurrence
  • Time Factors
  • Vitamin D / administration & dosage*


  • Calcium, Dietary
  • Vitamin D
  • Magnesium